China trial shows gum tissue stem cells help 55% of lifetime diabetes patients
Story summaryA randomised phase one clinical trial conducted by scientists and doctors from Shanghai and Guangzhou has achieved encouraging results in the treatment of Type 1 diabetes using stem cells extracted from gum tissue. More than half of those who received the treatment showed varying degrees of improvement, while one su…
Read at South China Morning PostOpens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.